Related Experiment Video
Updated: Aug 14, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Effects of bisphosphonate on the release of MMP-2 from cultured human osteoblasts
Y Ichinose1, K Migita, T Nakashima
1The First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Abstract:
Production of matrix metalloproteinases (MMPs) influences bone resorption. We investigated the role of bisphosphonates, potent inhibitors of bone resorption, on the production of MMP-2 from human osteoblasts. Bisphosphonates alone did not influence the amount of MMP-2 produced by human osteoblasts. However, in the presence of physiological concentrations of plasmin, bisphosphonates reduced the amount of MMP-2 in osteoblasts-conditioned media. Furthermore, bisphosphonates treatment induced degradation of MMP-2 in the presence of plasmin. Our results indicated that bisphosphonate, a divalent cation chelator, negatively regulated the longevity of MMP-2 in soluble phase plasmin-containing environment. These findings suggest that bisphosphonates inhibit bone resorption by abrogating MMP-2 protection induced by plasmin-mediated degradation.
Insights
Bisphosphonates do not affect matrix metalloproteinase-2 (MMP-2) production alone. However, they reduce MMP-2 levels and induce its degradation in the presence of plasmin, suggesting a novel mechanism for inhibiting bone resorption.
Area of Science:
- Biochemistry
- Cell Biology
- Bone Biology
Background:
- Matrix metalloproteinases (MMPs) play a crucial role in bone resorption.
- Bisphosphonates are potent inhibitors of bone resorption widely used in treating bone diseases.
- The precise molecular mechanisms by which bisphosphonates exert their effects are still under investigation.
Purpose of the Study:
- To investigate the effect of bisphosphonates on the production of matrix metalloproteinase-2 (MMP-2) by human osteoblasts.
- To determine if bisphosphonates modulate MMP-2 activity or stability in the presence of plasmin.
Main Methods:
- Human osteoblasts were cultured and treated with bisphosphonates.
- Conditioned media were analyzed for MMP-2 levels using biochemical assays.
- The interaction between bisphosphonates, MMP-2, and plasmin was investigated.
Main Results:
- Bisphosphonates alone did not alter the production of MMP-2 by osteoblasts.
- In the presence of physiological concentrations of plasmin, bisphosphonates significantly reduced MMP-2 levels in osteoblast-conditioned media.
- Bisphosphonate treatment promoted the degradation of MMP-2 when plasmin was present.
Conclusions:
- Bisphosphonates, acting as divalent cation chelators, negatively regulate the stability of MMP-2 in a plasmin-containing environment.
- These findings suggest that bisphosphonates may inhibit bone resorption by preventing plasmin-mediated protection and subsequent degradation of MMP-2.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Role of Matrix Metalloproteases in Degradation of ECM
A...

